APO RESEARCH · REPORT
Follicle Stimulating Hormone
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Product & engineering
Understand the product.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Selected research
Industry Research
Follicle Stimulating Hormone Industry Research Report 2026
Market perspective
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Read the full market overview
Report Scope
This report quantifies the global Follicle Stimulating Hormone market in terms of revenue (US$ million) and, where applicable, sales volume (k doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Follicle Stimulating Hormone Market by Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Follicle Stimulating Hormone Segment by Type
Recombinant FSH
Urinary FSH
Follicle Stimulating Hormone Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Follicle Stimulating Hormone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicle Stimulating Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Follicle Stimulating Hormone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant FSH
- Urinary FSH
Applications
- Infertility Treatment
- Assisted Reproductive Technology
Companies covered
- Merck Serono
- MSD
- IBSA
- Ferring
- Livzon
- Techwell
- GenSci
- Gedeon Richter
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Follicle Stimulating Hormone Market Size (2021-2032)
- 2.2.2 Global Follicle Stimulating Hormone Sales (2021-2032)
- 2.2.3 Global Follicle Stimulating Hormone Market Average Price (2021-2032)
- 2.3 Follicle Stimulating Hormone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Recombinant FSH
- 2.3.3 Urinary FSH
- 2.4 Follicle Stimulating Hormone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infertility Treatment
- 2.4.3 Assisted Reproductive Technology
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Follicle Stimulating Hormone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Follicle Stimulating Hormone Sales (k doses) of Manufacturers (2021-2026)
- 3.3 Global Follicle Stimulating Hormone Revenue of Manufacturers (2021-2026)
- 3.4 Global Follicle Stimulating Hormone Average Price by Manufacturers (2021-2026)
- 3.5 Global Follicle Stimulating Hormone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Follicle Stimulating Hormone, Product Type & Application
- 3.8 Global Manufacturers of Follicle Stimulating Hormone, Established Date
- 3.9 Global Follicle Stimulating Hormone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck Serono
- 4.1.1 Merck Serono Company Information
- 4.1.2 Merck Serono Business Overview
- 4.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
- 4.1.5 Merck Serono Recent Developments
- 4.2 MSD
- 4.2.1 MSD Company Information
- 4.2.2 MSD Business Overview
- 4.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 MSD Follicle Stimulating Hormone Product Portfolio
- 4.2.5 MSD Recent Developments
- 4.3 IBSA
- 4.3.1 IBSA Company Information
- 4.3.2 IBSA Business Overview
- 4.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
- 4.3.5 IBSA Recent Developments
- 4.4 Ferring
- 4.4.1 Ferring Company Information
- 4.4.2 Ferring Business Overview
- 4.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
- 4.4.5 Ferring Recent Developments
- 4.5 Livzon
- 4.5.1 Livzon Company Information
- 4.5.2 Livzon Business Overview
- 4.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
- 4.5.5 Livzon Recent Developments
- 4.6 Techwell
- 4.6.1 Techwell Company Information
- 4.6.2 Techwell Business Overview
- 4.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
- 4.6.5 Techwell Recent Developments
- 4.7 GenSci
- 4.7.1 GenSci Company Information
- 4.7.2 GenSci Business Overview
- 4.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
- 4.7.5 GenSci Recent Developments
- 4.8 Gedeon Richter
- 4.8.1 Gedeon Richter Company Information
- 4.8.2 Gedeon Richter Business Overview
- 4.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
- 4.8.5 Gedeon Richter Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Follicle Stimulating Hormone Product Portfolio
- 4.9.5 Teva Recent Developments
5 Global Follicle Stimulating Hormone Market Scenario by Region
- 5.1 Global Follicle Stimulating Hormone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Follicle Stimulating Hormone Sales by Region: 2021-2032
- 5.2.1 Global Follicle Stimulating Hormone Sales by Region: 2021-2026
- 5.2.2 Global Follicle Stimulating Hormone Sales by Region: 2027-2032
- 5.3 Global Follicle Stimulating Hormone Revenue by Region: 2021-2032
- 5.3.1 Global Follicle Stimulating Hormone Revenue by Region: 2021-2026
- 5.3.2 Global Follicle Stimulating Hormone Revenue by Region: 2027-2032
- 5.4 North America Follicle Stimulating Hormone Market Facts & Figures by Country
- 5.4.1 North America Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Follicle Stimulating Hormone Sales by Country (2021-2032)
- 5.4.3 North America Follicle Stimulating Hormone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Follicle Stimulating Hormone Market Facts & Figures by Country
- 5.5.1 Europe Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Follicle Stimulating Hormone Sales by Country (2021-2032)
- 5.5.3 Europe Follicle Stimulating Hormone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Follicle Stimulating Hormone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Follicle Stimulating Hormone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Follicle Stimulating Hormone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Follicle Stimulating Hormone Market Facts & Figures by Country
- 5.7.1 South America Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Follicle Stimulating Hormone Sales by Country (2021-2032)
- 5.7.3 South America Follicle Stimulating Hormone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Follicle Stimulating Hormone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Follicle Stimulating Hormone Sales by Type (2021-2032)
- 6.1.1 Global Follicle Stimulating Hormone Sales by Type (2021-2032) & (k doses)
- 6.1.2 Global Follicle Stimulating Hormone Sales Market Share by Type (2021-2032)
- 6.2 Global Follicle Stimulating Hormone Revenue by Type (2021-2032)
- 6.2.1 Global Follicle Stimulating Hormone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Type (2021-2032)
- 6.3 Global Follicle Stimulating Hormone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Follicle Stimulating Hormone Sales by Application (2021-2032)
- 7.1.1 Global Follicle Stimulating Hormone Sales by Application (2021-2032) & (k doses)
- 7.1.2 Global Follicle Stimulating Hormone Sales Market Share by Application (2021-2032)
- 7.2 Global Follicle Stimulating Hormone Revenue by Application (2021-2032)
- 7.2.1 Global Follicle Stimulating Hormone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Application (2021-2032)
- 7.3 Global Follicle Stimulating Hormone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Follicle Stimulating Hormone Value Chain Analysis
- 8.1.1 Follicle Stimulating Hormone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Follicle Stimulating Hormone Production Mode & Process
- 8.2 Follicle Stimulating Hormone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Follicle Stimulating Hormone Distributors
- 8.2.3 Follicle Stimulating Hormone Customers
9 Global Follicle Stimulating Hormone Analyzing Market Dynamics
- 9.1 Follicle Stimulating Hormone Industry Trends
- 9.2 Follicle Stimulating Hormone Industry Drivers
- 9.3 Follicle Stimulating Hormone Industry Opportunities and Challenges
- 9.4 Follicle Stimulating Hormone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst